Clover Health Investments Crop. ($CLOV) Stock Forecast: Down 6.7% Today

What is Clover Health Investments Crop.?

Clover Health (CLOV) is a healthcare technology company specializing in Medicare Advantage plans and innovative patient care solutions with a focus on achieving profitability through revenue growth.

Why is Clover Health Investments Crop. going down?

CLOV stock is down 6.7% on Mar 5, 2026 17:56

• Today's downturn in Clover Health's stock (CLOV) can be linked to various factors:
• Strong revenue growth and an increase in Medicare Advantage membership were overshadowed by higher net losses and loss per share in the recent SEC 10-K filing, causing concerns among investors about the company's profitability.
• The company's aim to reach GAAP profitability by 2026, while making progress in non-GAAP profitability, has raised doubts about its financial targets.
• Efforts to expand product offerings and geographic reach, as outlined in the Form 10-K, may result in higher operating expenses and competitive challenges, prompting investor wariness.
• General market volatility in the healthcare sector or broader market conditions could have influenced market sentiment, leading some investors to approach Clover Health's stock with more caution.

CLOV Price Chart

CLOV Technical Analysis

CLOV News

Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network

Clover Health has become the first payer to go live on a CMS Aligned Network and TEFCA, facilitating real-time patient access to clinical and claims data in standardized FHIR formats. This achievement, made possible by a collaboration with Kno2 and Clover's subsidiary Counterpart Health, demonstrates that nationwide interoperable data exchange is achievable today. It allows patients to securely request health information and aims to enhance coordinated care within a value-based model.

https://www.bitget.com/amp/news/detail/12560605237920

Clover Health (CLOV) targets 2026 GAAP profitability after 40% revenue growth

Clover Health reported strong 40% revenue growth in 2025, reaching $1.9 billion, and increased Medicare Advantage membership by 38% to 113,803. Despite a GAAP net loss of $86 million in 2025, the company achieved non-GAAP profitability with $22 million in Adjusted EBITDA and $20 million in Adjusted Net Income. Clover Health projects its first full year of GAAP net income profitability in 2026, with revenue guidance between $2.81 billion and $2.92 billion and Adjusted EBITDA of $50-$70 million.

https://www.stocktitan.net/sec-filings/CLOV/8-k-clover-health-investments-corp-de-reports-material-event-310546a8b39d.html

CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-K Report

Clover Health Investments, Corp. has released its annual Form 10-K report, detailing financial performance, business operations, and strategic initiatives. The company reported a significant increase in total revenues but also higher net losses and loss per share. Clover Health continues to focus on its Clover Assistant platform, geographical expansion, and new product launches like Counterpart Health, while navigating challenges in profitability, operational and regulatory risks, and market competition.

https://www.tradingview.com/news/tradingview:f42978c1b2da7:0-clover-health-investments-corp-de-sec-10-k-report/

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Down 7.8% Today

Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 5.3% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Up 5.3% Today

Welltower Inc. ($WELL) Stock Forecast: Down 0.9% Today

Tapestry Inc. ($TPR) Stock Forecast: Down 5.0% Today

Booking Holdings Inc. ($BKNG) Stock Forecast: Up 7.8% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Down 5.1% Today

Corning Incorporated ($GLW) Stock Forecast: Down 8.0% Today

FuelCell Energy ($FCEL) Stock Forecast: Down 6.5% Today

Newell Brands Inc. ($NWL) Stock Forecast: Down 5.3% Today

Clover Health Investments Crop. Price History

23.09.2025 - CLOV Stock was up 5.5%

• Participation in a global healthcare conference suggests potential positive developments or strategic partnerships for Clover Health.
• Investors may interpret the conference participation as a signal of industry recognition and future growth prospects for the company.
• The rise in CLOV's stock price could be linked to increased investor confidence after the announcement of the CFO's presentation at the conference.
• Market participants could be expecting favorable insights or announcements during the conference, leading to a surge in CLOV's stock price.

05.10.2025 - CLOV Stock was down 27.8%

• The bearish movement in CLOV could be attributed to the disappointing earnings report for Q3, with the company reporting break-even earnings and missing revenue expectations.
• Investors might be concerned about the company's future growth prospects, as indicated by the negative earnings surprise.
• The market reaction could also reflect uncertainty about Clover Health Investments' ability to maintain its competitive edge in the healthcare technology sector.
• Overall, the bearish trend in CLOV today could be a result of investors reevaluating the stock's valuation in light of the underwhelming financial performance in the recent quarter.

22.00.2026 - CLOV Stock was up 5.3%

• The rise in CLOV stock could be linked to the CEO's recent share sales, potentially indicating confidence in the company's future.
• Upbeat forecasts for profitability in 2026 and an annual increase in Medicare Advantage membership likely boosted investor confidence and led to the stock's upward movement.
• Despite a lack of profitability over the past year, the expectation of turning profitable this year and being deemed slightly undervalued by InvestingPro could have additionally stimulated investor interest in CLOV.

04.02.2026 - CLOV Stock was up 6.8%

• The company recorded remarkable 40% revenue growth in 2025, hitting $1.9 billion, and saw a 38% increase in its Medicare Advantage membership to 113,803. This strong financial performance likely influenced the stock's positive movement.
• Despite reporting a GAAP net loss in 2025, Clover Health achieved non-GAAP profitability, indicating effective operational practices and cost control measures.
• Clover Health's forecast of achieving GAAP net income profitability in 2026, coupled with revenue guidance ranging between $2.81 billion and $2.92 billion, presented a promising future for investors, driving bullish sentiment in the market.
• The company's strategic efforts, including enhancements to its Clover Assistant platform, expansion into new regions, and introduction of new products, showcase its dedication to growth and innovation, further enhancing investor trust in the stock.

05.02.2026 - CLOV Stock was down 6.7%

• Today's downturn in Clover Health's stock (CLOV) can be linked to various factors:
• Strong revenue growth and an increase in Medicare Advantage membership were overshadowed by higher net losses and loss per share in the recent SEC 10-K filing, causing concerns among investors about the company's profitability.
• The company's aim to reach GAAP profitability by 2026, while making progress in non-GAAP profitability, has raised doubts about its financial targets.
• Efforts to expand product offerings and geographic reach, as outlined in the Form 10-K, may result in higher operating expenses and competitive challenges, prompting investor wariness.
• General market volatility in the healthcare sector or broader market conditions could have influenced market sentiment, leading some investors to approach Clover Health's stock with more caution.

06.10.2025 - CLOV Stock was down 7.2%

• Highlighting CLOV as a great choice for value investors due to recent strong momentum and reasonable prices might have attracted a lot of attention and buying interest.
• Break-even earnings for Q3 with negative surprises on earnings and positive surprises on revenue could have led to disappointment among investors, causing a sell-off and contributing to the bearish movement.
• Mixed signals from market participants, expecting momentum but receiving disappointing earnings clues, likely resulted in increased volatility and downward pressure on CLOV's stock price.

01.07.2025 - CLOV Stock was down 5.9%

• Vicky Bruner's recent appointment as Vice President of Operations at Counterpart Health, a Clover Health subsidiary, suggests a strategic focus on expansion and enhancing operational efficiency.
• Despite this promising development, reactions from investors to the announcement may have been negative, potentially reflecting concerns about market sentiment or internal challenges faced by the company.
• The downward movement in CLOV's stock price could be attributed to broader market dynamics or selling pressure from traders capitalizing on previous price increases.

08.06.2025 - CLOV Stock was up 8.8%

• CLOV stock saw a significant increase, with share prices rising notably.
• The upcoming second-quarter earnings report set for August 5th may be influencing investor confidence and attention towards the stock.
• Expectations of favorable financial outcomes or strategic updates in the earnings report could be driving the recent strong performance of CLOV stock.
• Investor response to potential growth opportunities or internal advancements within the company could be boosting the stock's upward trajectory.

03.01.2026 - CLOV Stock was down 5.6%

• The bearish movement in CLOV stock today may be linked to the upcoming release of its fourth quarter and full year 2025 financial results. Investors seem cautious about the company's performance, resulting in a sell-off of shares ahead of the announcement. Market sentiment appears to be affected by concerns about Clover Health Investments, Corp.'s financial health and growth prospects.

06.07.2025 - CLOV Stock was down 22.9%

• Q2 earnings of Clover Health were in line with expectations, with a 34% revenue increase.
• Despite this, the stock declined as the company raised its Insurance BER guidance, sparking worries about margin pressures.
• The adverse outlook on insurance benefits expense ratio (BER) appears to have unsettled investors, resulting in the bearish trend in CLOV's stock price.

23.08.2025 - CLOV Stock was up 7.9%

• CLOV is still considered undervalued, making it an appealing option for investors seeking promising stocks at reasonable prices.
• The bullish movement in CLOV is seen as an opportunity for investors looking for growth potential at an attractive price.
• This positive momentum reflects optimism among investors about Clover Health Investments' future prospects, leading to an increase in its stock price.
• The bullish movement in CLOV today could be linked to growing investor interest and favorable sentiment regarding the company's potential for growth.

22.06.2025 - CLOV Stock was up 7.7%

• Participation in the Canaccord Genuity 45th Annual Growth Conference could have positively influenced investor sentiment towards Clover Health.
• The conference presents an opportunity for Clover Health to highlight its growth strategies and future developments, potentially boosting investor confidence.
• Speculation about the conference yielding valuable insights and partnerships likely contributed to today's bullish trend in CLOV stock.